Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis.

Ibrahim-Achi, Zeina; de Vera-González, Antonia; González-Delgado, Alejandra; López-Mejías, Raquel; González-Gay, Miguel Ángel; Ferraz-Amaro, Iván

Ibrahim-Achi, Zeina; de Vera-González, Antonia; González-Delgado, Alejandra; López-Mejías, Raquel; González-Gay, Miguel Ángel; Ferraz-Amaro, Iván.

Afiliação

Ibrahim-Achi Z; Division of Angiology and Vascular Surgery, Hospital Universitario de Canarias, Tenerife, Spain.
de Vera-González A; Division of Central Laboratory, Hospital Universitario de Canarias, Tenerife, Spain.
González-Delgado A; Division of Central Laboratory, Hospital Universitario de Canarias, Tenerife, Spain.
López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
González-Gay MÁ; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander; Division of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid; and University of Cantabria, IDIVAL, Santander, Spain. miguelaggay@hotmail.com.
Ferraz-Amaro I; Department of Internal Medicine, University of La Laguna (ULL), Tenerife; and Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. iferrazamaro@hotmail.com.

Clin Exp Rheumatol ; 2023 Dec 04.

Article em En | MEDLINE | ID: mdl-38079332

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha